Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cance…
Kuribayashi T; Ohashi K; Nishii K; Ninomiya K; Tsubata Y; Ishikawa N; Kodani M; Kanaji N; Yamasaki M; Fujitaka K; Kuyama S; Takigawa N; Fujimoto N; Kubota T; Inoue M; Fujiwara K; Harita S; Takata I; Takada K; Okawa S; Kiura K; Hotta K.
J Cancer Res Clin Oncol
(Unknown)
Published: 2024
The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in pati…
Olbrich A; Niemeyer J; Seiffert H; Ebel S; Gros O; Lordick F; Forstmeyer D; Seehofer D; Rademacher S; Denecke T; Matz-Soja M; Berg T; van Bömmel F.
J Cancer Res Clin Oncol
(Unknown)
Published: 2024